Scarica l'app Stockscreener
1.08
32.71%
0.2662
Dopo l'orario di chiusura:
1.05
-0.03
-2.78%
Precedente Chiudi:
$0.8138
Aprire:
$0.91
Volume 24 ore:
13.67M
Relative Volume:
27.65
Capitalizzazione di mercato:
$17.99M
Reddito:
-
Utile/perdita netta:
$-12.66M
Rapporto P/E:
-0.9802
EPS:
-1.1018
Flusso di cassa netto:
-
1 W Prestazione:
+22.76%
1M Prestazione:
+73.35%
6M Prestazione:
+2.86%
1 anno Prestazione:
-22.30%
Intervallo 1D:
$0.84
$1.14
Intervallo di 1 settimana:
$0.77
$1.14
Portata 52W:
$0.4026
$1.60
Inspira Technologies Oxy B H N Ltd Stock (IINN) Company Profile
Nome
Inspira Technologies Oxy B H N Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta IINN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IINN
Inspira Technologies Oxy B H N Ltd
|
1.08 | 17.99M | 0 | -12.66M | 0 | -1.1018 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspira Technologies Oxy B H N Ltd Borsa (IINN) Ultime notizie
IINN’s Financial Health: Exploring Inspira Technologies Oxy B.H.N. Ltd’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Inspira Technologies’ ART100 Gains Traction in U.S. Hospitals - TipRanks
Inspira Technologies (IINN) Sees Boost in Commercial Interest Due to ART100 System | IINN Stock News - GuruFocus
Inspira Technologies Begins Commercial Adoption of FDA-Cleared ART100 System, Driving Global Interest in Life-Support Innovations - Nasdaq
Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions - The Manila Times
Inspira's ART100 Life Support System Deployed at Top US Hospitals | IINN Stock News - Stock Titan
Citadel Advisors LLC Has $88,000 Stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira Technologies boosts production of FDA-cleared system By Investing.com - Investing.com South Africa
CORRECTIONInspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies (IINN) Boosts Production for Anticipated Eu - GuruFocus
Inspira Technologies boosts production of FDA-cleared system - Investing.com
Inspira Technologies Boosts ART100 Production Amid European Negotiations - TipRanks
Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies Scales Up Production of INSPIRA ART100 System Amid European Procurement Negotiations - Nasdaq
Research Analysts Offer Predictions for IINN FY2025 Earnings - Defense World
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Raised to Strong-Buy at Litchfield Hills Research - Defense World
Litchfield Hills Initiates Coverage of Inspira Technologies Oxy B.H.N. (IINN) with Buy Recommendation - Nasdaq
Inspira Technologies Oxy (IINN) Coverage Initiated with 'Buy' Rating | IINN Stock News - GuruFocus
Inspira Technologies (IINN) Receives Buy Rating from Analyst | I - GuruFocus
Inspira Technologies Receives $2 Price Target And Buy Rating: Everything You Need To Know - MENAFN.com
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Trading Up 9.3% – Still a Buy? - Defense World
Inspira Technologies Announces Shareholder Meeting to Address Nasdaq Compliance - TipRanks
Inspira Technologies ramps up ART100 system commercialization By Investing.com - Investing.com South Africa
Inspira (IINN) Strategizes for Enhanced U.S. Commercialization o - GuruFocus
Inspira Technologies Begins Rollout of ART100 System; Shares Rise - marketscreener.com
Inspira Technologies Initiates Global Commercial Rollout of FDA -Cleared ART100 System - marketscreener.com
Inspira Technologies ramps up ART100 system commercialization - Investing.com Australia
Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System - The Manila Times
Inspira Technologies Announces Strategic Shift to Accelerate Commercialization of INSPIRA ART100 System - Nasdaq
Inspira's FDA-Cleared Alternative to Mechanical Ventilation Begins Worldwide Launch After US Success - Stock Titan
Inspira Technologies Restructures Executive Team for Strategic Alignment - TipRanks
Inspira Technologies restructures executive team By Investing.com - Investing.com South Africa
Inspira Technologies (IINN) Restructures Leadership for Strategi - GuruFocus
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives - The Manila Times
Inspira Technologies restructures executive team - Investing.com
Inspira Technologies Co-Founder Exits President Role as Company Pivots Strategy - Stock Titan
Inspira Technologies stock hits 52-week low at $0.46 By Investing.com - Investing.com South Africa
Inspira Technologies stock hits 52-week low at $0.46 - Investing.com
Inspira Technologies Shareholders Approve Key Agenda Items at May 2025 Meeting - TipRanks
Renaissance Technologies LLC Boosts Stock Position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira’s ART100 system set for transplant validation in Israel By Investing.com - Investing.com South Africa
Stock Performance Spotlight: Inspira Technologies Oxy B.H.N. Ltd (IINN) Ends the Day at 0.58, Down by -3.78 - DWinneX
Inspira’s ART100 System Gains Approval for Organ Transplant Use in Israel - TipRanks
Inspira’s ART100 system set for transplant validation in Israel - Investing.com
Inspira Technologies Oxy B H N Ltd Azioni (IINN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.54%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):